Collagen supplements have long been sold on big promises and thin evidence. A new randomized controlled trial in Frontiers in Physiology gives lifters something more concrete to chew on. It also leaves some big questions unanswered, and you should know which ones before you buy a tub.
The Headline Finding
Researchers from Germany, Denmark and Austria put 29 healthy men through 12 weeks of high-load resistance training at 70-85% of their one-rep max. Half took 15 g of specific collagen peptides (SCP) daily. The other half took a placebo.
Before and after the program, the team took biopsies from the vastus lateralis, the outer quad muscle, to measure the collagen inside the muscle itself.
The collagen type I content rose by 29.8% in the SCP group versus 9.9% in the placebo group (p = 0.026). Both groups trained hard and both improved. The collagen group's increase was roughly three times larger.
The authors describe this as an increase in endomysial collagen type I. The endomysium is the thin connective tissue sleeve wrapped around each muscle fiber. It helps transmit force from the muscle fibers toward the tendons and skeleton.
Why Muscle Connective Tissue Matters
Most gym talk centers on the contractile part of muscle. The extracellular matrix is the scaffolding around it, and it matters for structural support and force transmission. Collagen is the main structural protein in that scaffolding, and it adapts to mechanical loading. The authors suggest that the extra collagen I seen with SCP may contribute to better structural support of muscle fibers. That is a hypothesis, not something the study proved.
What Didn't Separate the Groups
The picture is not entirely one-sided:
- Collagen types III and IV rose significantly across the pooled sample, which means training alone did that. There was no significant difference between SCP and placebo.
- Fibroblast density, a measure of the cells that make collagen, did not change within or between groups.
So the benefit was specific to type I collagen. It was not a general boost to every collagen type. The study also doesn't show that supplementation made muscle cells produce more collagen, since the fibroblast count stayed flat.
What Was and Wasn't Measured
The primary outcomes were collagen amounts in muscle tissue and fibroblast density. The published abstract does not report strength, muscle size, tendon health, injury rates or performance results. This study therefore cannot tell you that collagen peptides will make you stronger, bigger, faster or less injury-prone.
It also does not show that more collagen type I in the endomysium is functionally better for a lifter. The conclusion is carefully worded: the increase "may contribute" to structural support.
Other limits to keep in mind:
- Small sample: 29 participants total.
- Men only: All participants were healthy males, so these results don't speak to women, older adults or people with injuries.
- Single muscle: Biopsies came from one muscle, the vastus lateralis.
- 12 weeks: Longer-term effects are unknown.
This is human trial data, not an animal or cell-culture study. That is a point in its favor, but the abstract does not test mechanisms. Explanations for how collagen peptides might act belong to hypothesis territory until further work confirms them.
The Conflict-of-Interest Note
One co-author, Steffen Oesser of the Collagen Research Institute in Kiel, has received honoraria for speaking at symposia on the effects of collagen peptides. He is also a co-inventor on patents related to collagen peptide supplementation. The other authors declared no commercial or financial conflicts.
That doesn't invalidate the results. The trial was randomized and placebo-controlled, and tissue biopsies are a hard endpoint. But it is a reason to want independent replication, especially since the benefit is confined to one collagen type and rests on a modest sample.
Practical Takeaways
Dose: The trial used 15 g of specific collagen peptides daily. The abstract doesn't say anything about timing relative to workouts, so there is no evidence-based reason to obsess over it. Daily consistency over the full 12 weeks is what the study actually tested.
Who it might interest: Lifters who already train hard, at roughly 70-85% of 1RM, and are curious about connective tissue support. The study design is the closest match to that profile.
Who should skip or be cautious:
- Anyone hoping for proven strength or muscle-size gains. This paper didn't report them.
- Women, older adults and people with injuries, who weren't studied.
- Anyone with food allergies or medical conditions, who should check with a clinician or dietitian first, since collagen products are animal-derived.
- Anyone expecting collagen to replace training. Both groups got stronger signals from lifting alone, as collagen III and IV rose regardless.
Product note: The trial used specific collagen peptides. Don't assume every collagen powder is interchangeable with what was tested.
Bottom Line
In this trial, 15 g a day of collagen peptides plus heavy lifting increased intramuscular collagen type I about three times as much as lifting plus placebo. That is a real, biopsy-confirmed result, but only a modest piece of evidence. Whether it translates into stronger muscles, tougher tendons or fewer injuries remains unproven. Treat collagen as an interesting, possibly useful add-on to a solid training program, not a shortcut.
